Total cannabis net revenue hovered $70.3 million, excluding provisions of $2.7 million That's up 11% over the second quarter of 2020 Medical cannabis net revenue reached $38.9 million — up 42% versus the second quarter of 2020 That jump was due to a 562% increase in high margin international medical sales Aurora experienced an adjusted EBITDA loss of $12.1 million That's an improvement of $53.1 million over the second quarter of 2020 The company reported improved cash use by more than 74% compared to the second quarter of 2020 As of Feb. 10, the Edmonton, Canada-based cannabis producer h...